PREVALENCE AND FACTORS ASSOCIATED WITH SEVERE COVID-19 IN ADULTS HOSPITALIZED IN THE STATE OF PARANÁ
DOI:
https://doi.org/10.25110/arqsaude.v28i2.2024-10873Keywords:
Coronavírus, Pandemias, Cuidados Críticos, EpidemiologiaAbstract
Objective: To analyze the prevalence and factors associated with the need for intensive care by adults hospitalized due to Covid-19 in the state of Paraná. Method: This was a cross-sectional study of compulsory notifications of Severe Acute Respiratory Syndrome associated with Covid-19. Poisson regression models were applied in the univariate and multivariate analysis, with associations estimated by Prevalence Ratio. Results: 61,213 hospitalizations due to Covid-19 were recorded in the state. The majority of patients were between 45 and 59 years old, male, white and had no risk factors/comorbidities. The severity and need for intensive care were associated with age, gender, race/color, use of influenza immunization, diagnosis of previous comorbidities, having presented moderate/severe symptoms and place of residence other than the municipality of hospitalization. Conclusion: The worst Covid-19 outcomes were influenced by sociodemographic, clinical and epidemiological factors, which were related to the severity of the disease and the need for intensive care. A high prevalence of hospitalization in Intensive Care Units was identified, given the intrinsic and extrinsic characteristics of individuals.
Downloads
References
BARBOSA, I. R.; AIQUOC, K. M.; SOUZA, T. A. RAÇA E SAÚDE - Múltiplos olhares sobre a saúde da população negra no Brasil. 1. ed. [s.n.]. Natal, RN: EDUFRN, 2021. p. 274 p
BRASIL. Ministério da Saúde. Sintomas. Disponível em: https://www.gov.br/saude/pt-br/coronavirus/sintomas. Acesso em: 20 set. 2023.
COSTENARO, R. R. et al. Caracterização dos pacientes internados em Uti-Covid com evolução a Óbito. Arquivos de Ciências da Saúde da UNIPAR, v. 27, n. 6, p. 2942–2959, 2023.
CRUZ-TERAN, C. et al. Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy. Adv. Drug Deliv. Rev., v. 169, p. 100-117, 2021.
FILHO, P. C. L. et al. Impact of Socioeconomic Vulnerability on Covid-19 Outcomes and Social Distancing in Brazil. Arquivos de Ciências da Saúde da UNIPAR, v. 27, n. 5, p. 3103-3115, 2023.
GOES, E. F.; RAMOS, D. O.; FERREIRA, A. J. Racial health inequalities and the COVID-19 pandemic. Trab. Educ. Saúde, e00278110, 2020.
HIPPISLEY-COX, J. et al. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study. BMJ, v. 374, n. 2244, 2021.
HOOPER, M. W.; NÁPOLES, A. M.; PÉREZ-STABLE, E. J. COVID-19 and Racial/Ethnic Disparities. JAMA, v. 323, n. 24, p. 2466-2467, 2020.
HU, J. et al. Race, Ethnicity, Neighborhood Characteristics, and In-Hospital Coronavirus Disease-2019 Mortality. Med. Care., v. 59, n. 10, p. 888-892, 2021.
IGOE, M. et al. Geographic disparities and predictors of COVID-19 hospitalization risks in the St. Louis Area, Missouri (USA). BMC Public Health, v. 22, n. 231, 2022.
ISER, B. P. M. et al. Suspected COVID-19 case definition: a narrative review of the most frequent signs and symptoms among confirmed cases. Epidemiol. Serv. Saude, v. 29, n. 3, e2020233, 2020.
ISLÃ, N. et al. COVID-19 mortality: a complex interplay of sex, gender and ethnicity. Eur. J. Public. Health, v. 25, ckaa150, 2020.
KIM, C. W.; ARONOW, W. S. COVID-19, cardiovascular diseases and cardiac troponins. Future Cardiol., v. 18, n. 2, 2021.
LI, H. et al. A Comprehensive Review of Coronavirus Disease 2019: Epidemiology, Transmission, Risk Factors, and International Responses. Yonsei Med. J., v. 62, n. 1, p. 1-11, 2021.
MONTEIRO, R. P. et al. The dark side of Brazil: Effects of dark traits on general COVID-19 worry and responses against the pandemic. Pers. Individ. Dif., v. 185, n. 111247, 2022.
MOREIRA, A. G. et al. Clinical and epidemiological aspects of patients with COVID-19 seen at a reference center in the Amazon. Conjecturas, v. 22, n. 1, p. 586-597, 2022.
MOUSAVIZADEH, L.; GHASEMI, S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J. Microbiol. Immunol. Infect, v. 54, n. 2, p. 159-163, 2021.
NORONHA, K. V. M. S. et al. The COVID-19 pandemic in Brazil: analysis of supply and demand of hospital and ICU beds and mechanical ventilators under different scenarios. Cad. Saude Publica, v. 36, n. 6, e00115320, 2020.
PASTOR-BARRIUSO, R. et al. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study. BMJ, v. 371, n. 4509, 2020.
RAHMAN, A.; SATHI, N. J. Risk Factors of the Severity of COVID-19: a Meta-Analysis. MedRxiv., v. 75, n. 7, e13916, 2020.
REYES-SÁNCHEZ, F. et al. Fraction of COVID-19 hospitalizations and deaths attributable to chronic diseases. Prev. Med., v. 155, n. 106917, 2022.
ROZENBERG, S.; VANDROMME, J.; MARTIN, C. Are we equal in adversity? Does Covid-19 affect women and men differently? Maturitas, v. 138, p. 62-68, 2020.
SANOUDOU, D. et al. Obesity, metabolic phenotypes and COVID-19. Metabolism, v. 128, n. 155121, 2022.
SONG, S. W. et al. Symptoms and Characteristics Which Require Attention During COVID-19 Screening at a Port of Entry. J. Korean Med. Sci., v. 36, n. 2, e14, 2021.
SOUSA, A. R. et al. Vulnerabilidades percebidas pelos homens no contexto da pandemia de Covid-19. Rev. René, v. 22, e60296, 2021.
TURNER-MUSA, J.; AJAYI, O.; KEMP, L. Examining Social Determinants of Health, Stigma, and COVID-19 Disparities. Healthcare (Basel)., v.8, n. 2, p. 168, 2020.
USHIGOME, E. et al. Impact of untreated diabetes and COVID-19-related diabetes on severe COVID-19. Heliyon, v. 8, n. 1, e08801, 2022.
WANG, Y. et al. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. J. Med. Virol., v. 29, n. 101002, 2020.
WORLD HEALTH ORGANIZATION (WHO). Ageing. Disponível em: https://www.who.int/health-topics/ageing#tab=tab_1. Acesso em: 22 set. 2023.
WORLD HEALTH ORGANIZATION (WHO). WHO Coronavirus (COVID-19) Dashboard. Disponível em: https://covid19.who.int/. Acesso em: 17 set. 2023.
XAVIER, A. et al. COVID-19: clinical and laboratory manifestations in novel coronavirus infection. J. Bras. Patol. Med. Lab., v. 56, p. 1-9, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Arquivos de Ciências da Saúde da UNIPAR
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os Direitos Autorais para artigos publicados são de direito da revista. Em virtude da aparecerem nesta revista de acesso público, os artigos são de uso gratuito, com Creative Commons Attribution 4.0 International License.
A revista se reserva o direito de efetuar, nos originais, alterações de ordem normativa, ortográfica e gramatical, com vistas a manter o padrão culto da língua e a credibilidade do veículo. Respeitará, no entanto, o estilo de escrever dos autores.
Alterações, correções ou sugestões de ordem conceitual serão encaminhadas aos autores, quando necessário. Nesses casos, os artigos, depois de adequados, deverão ser submetidos a nova apreciação.
As opiniões emitidas pelos autores dos artigos são de sua exclusiva responsabilidade.
